Safety and efficacy of immune checkpoint inhibitors as a bridge to allogeneic hematopoietic stem cell transplantation in classical Hodgkin lymphoma: A systematic review and meta-analysis
Safety and efficacy of immune checkpoint inhibitors as a bridge to allogeneic hematopoietic stem cell transplantation in classical Hodgkin lymphoma: A systematic review and meta-analysis. // Transplant Immunology. – URL: https://www.sciencedirect.com/science/article/pii/S096632742600078X?dgcid=rss_sd_all
Safety and efficacy of immune checkpoint inhibitors as a bridge to allogeneic hematopoietic stem cell transplantation in classical Hodgkin lymphoma: A systematic review and meta-analysis. Transplant Immunology. https://www.sciencedirect.com/science/article/pii/S096632742600078X?dgcid=rss_sd_all
“Safety and efficacy of immune checkpoint inhibitors as a bridge to allogeneic hematopoietic stem cell transplantation in classical Hodgkin lymphoma: A systematic review and meta-analysis.” Transplant Immunology.
@article{article70231,
title = {Safety and efficacy of immune checkpoint inhibitors as a bridge to allogeneic hematopoietic stem cell transplantation in classical Hodgkin lymphoma: A systematic review and meta-analysis},
journal = {Transplant Immunology},
url = {https://www.sciencedirect.com/science/article/pii/S096632742600078X?dgcid=rss_sd_all}
}